Mass Cytometry Defines Virus-Specific CD4+ T Cells in Influenza Vaccination. Academic Article uri icon

Overview

abstract

  • The antiviral response to influenza virus is complex and multifaceted, involving many immune cell subsets. There is an urgent need to understand the role of CD4+ T cells, which orchestrate an effective antiviral response, to improve vaccine design strategies. In this study, we analyzed PBMCs from human participants immunized with influenza vaccine, using high-dimensional single-cell proteomic immune profiling by mass cytometry. Data were analyzed using a novel clustering algorithm, denoised ragged pruning, to define possible influenza virus-specific clusters of CD4+ T cells. Denoised ragged pruning identified six clusters of cells. Among these, one cluster (Cluster 3) was found to increase in abundance following stimulation with influenza virus peptide ex vivo. A separate cluster (Cluster 4) was found to expand in abundance between days 0 and 7 postvaccination, indicating that it is vaccine responsive. We examined the expression profiles of all six clusters to characterize their lineage, functionality, and possible role in the response to influenza vaccine. Clusters 3 and 4 consisted of effector memory cells, with high CD154 expression. Cluster 3 expressed cytokines like IL-2, IFN-γ, and TNF-α, whereas Cluster 4 expressed IL-17. Interestingly, some participants had low abundance of Clusters 3 and 4, whereas others had higher abundance of one of these clusters compared with the other. Taken together, we present an approach for identifying novel influenza virus-reactive CD4+ T cell subsets, a method that could help advance understanding of the immune response to influenza, predict responsiveness to vaccines, and aid in better vaccine design.

publication date

  • December 11, 2020

Research

keywords

  • CD4-Positive T-Lymphocytes
  • Immunologic Memory
  • Influenza Vaccines
  • Influenza, Human
  • T-Lymphocyte Subsets

Identity

PubMed Central ID

  • PMC7891553

Scopus Document Identifier

  • 85107813336

Digital Object Identifier (DOI)

  • 10.4049/immunohorizons.1900097

PubMed ID

  • 33310880

Additional Document Info

volume

  • 4

issue

  • 12